Evidence map

ReviewEndocrine2026

From diabetes to tumor growth: unravelling the impact of glucose-lowering therapies.

R Modica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42081011